| Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1, 3-dimethyluric acid formation YC Kim, AK Lee, JH Lee, I Lee, DC Lee, SH Kim, SG Kim, MG Lee European journal of pharmaceutical sciences 26 (1), 114-123, 2005 | 84 | 2005 |
| Comparative bioavailability of silibinin in healthy male volunteers. YC Kim, EJ Kim, ED Lee, JH Kim, SW Jang, YG Kim, JW Kwon, WB Kim, ... International journal of clinical pharmacology and therapeutics 41 (12), 593-596, 2003 | 81 | 2003 |
| Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect JH Shin, KY Choi, YC Kim, MG Lee Antimicrobial agents and chemotherapy 48 (5), 1756-1762, 2004 | 58 | 2004 |
| Pharmacokinetics of DA‐8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first‐pass effects HJ Shim, YC Kim, KJ Park, DS Kim, JW Kwon, WB Kim, MG Lee Journal of pharmaceutical sciences 92 (11), 2185-2195, 2003 | 45 | 2003 |
| Hispolon from Phellinus linteus induces apoptosis and sensitizes human cancer cells to the tumor necrosis factor-related apoptosis-inducing ligand through upregulation of death … JIHUN KIm, YC Kim, B Park Oncology reports 35 (2), 1020-1026, 2016 | 40 | 2016 |
| Discovery of a novel highly selective histamine H4 receptor antagonist for the treatment of atopic dermatitis K Ko, HJ Kim, PS Ho, SO Lee, JE Lee, CR Min, YC Kim, JH Yoon, EJ Park, ... Journal of Medicinal Chemistry 61 (7), 2949-2961, 2018 | 38 | 2018 |
| Practical approaches on the long-acting injections YC Kim, KA Min, DJ Jang, TY Ahn, JH Min, BE Yu, KH Cho Journal of Pharmaceutical Investigation 50, 147-157, 2020 | 37 | 2020 |
| Flurbiprofen-loaded solid SNEDDS preconcentrate for the enhanced solubility, in-vitro dissolution and bioavailability in rats RM Kim, DJ Jang, YC Kim, JH Yoon, KA Min, HJ Maeng, KH Cho Pharmaceutics 10 (4), 247, 2018 | 30 | 2018 |
| Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin YC Kim, EY Oh, SH Kim, MG Lee Biopharmaceutics & drug disposition 27 (2), 85-92, 2006 | 30 | 2006 |
| Dose-Independent ADME Properties and Tentative Identification of Metabolites of α-Mangostin from Garcinia mangostana in Mice by Automated Microsampling … SY Han, BH You, YC Kim, YW Chin, YH Choi PLoS One 10 (7), e0131587, 2015 | 29 | 2015 |
| Effects of 1α, 25-dihydroxyvitamin D3, the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat YC Kim, IB Kim, CK Noh, HP Quach, IS Yoon, ECY Chow, M Kim, HE Jin, ... Journal of Pharmaceutical Sciences 103 (11), 3793-3805, 2014 | 28 | 2014 |
| Effect of CYP3A1 (23) induction on clarithromycin pharmacokinetics in rats with diabetes mellitus YC Kim, JH Lee, SH Kim, MG Lee Antimicrobial agents and chemotherapy 49 (6), 2528-2532, 2005 | 25 | 2005 |
| Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin YC Kim, EY Oh, SH Kim, MG Lee Biopharmaceutics & drug disposition 26 (8), 371-378, 2005 | 21 | 2005 |
| Interspecies pharmacokinetic scaling of DA‐8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics HJ Shim, YC Kim, JH Lee, JW Kwon, WB Kim, YG Kim, SH Kim, MG Lee Biopharmaceutics & drug disposition 26 (7), 269-277, 2005 | 20 | 2005 |
| Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats … CY Ahn, SK Bae, YS Jung, I Lee, YC Kim, MG Lee, WG Shin Drug metabolism and disposition 36 (7), 1233-1241, 2008 | 19 | 2008 |
| Pharmacokinetics of tolbutamide and its metabolite 4‐hydroxy tolbutamide in poloxamer 407‐induced hyperlipidemic rats MR Choi, MH Kwon, YY Cho, HD Choi, YC Kim, HE Kang Biopharmaceutics & drug disposition 35 (5), 264-274, 2014 | 18 | 2014 |
| Determination of cefadroxil in rat plasma and urine using LC–MS/MS and its application to pharmacokinetic and urinary excretion studies HE Jin, IB Kim, YC Kim, KH Cho, HJ Maeng Journal of Chromatography B 947, 103-110, 2014 | 18 | 2014 |
| Metabolic stability of D-allulose in biorelevant media and hepatocytes: Comparison with fructose and erythritol HJ Maeng, JH Yoon, KH Chun, ST Kim, DJ Jang, JE Park, YH Kim, ... Foods 8 (10), 448, 2019 | 17 | 2019 |
| Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA‐8159, a new erectogenic, in rats YC Kim, HJ Shim, JH Lee, SH Kim, JW Kwon, WB Kim, MG Lee Biopharmaceutics & drug disposition 26 (6), 233-241, 2005 | 17 | 2005 |
| Dose‐independent pharmacokinetics of torasemide after intravenous and oral administration to rats DY Lee, JY Kim, YC Kim, JW Kwon, WB Kim, MG Lee Biopharmaceutics & drug disposition 26 (5), 173-182, 2005 | 17 | 2005 |
